These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11365989)

  • 1. Expanded access program begins.
    Highleyman L
    BETA; 1998 Oct; ():3. PubMed ID: 11365989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amprenavir (Agenerase) now available in expanded access.
    AIDS Treat News; 1998 Oct; (No 304):5. PubMed ID: 11365864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental drug available.
    Vazquez E
    Posit Aware; 1998; 9(6):17. PubMed ID: 11366472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amprenavir (Agenerase) receives FDA approval. Food and Drug Administration.
    Highleyman L
    BETA; 1999 Apr; 12(2):3. PubMed ID: 11366693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amprenavir: a new protease inhibitor nears approval.
    Highleyman L
    BETA; 1999 Jan; 12(1):8-9. PubMed ID: 11367244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trials for protease failure.
    Posit Aware; 1998; 9(5):16-7. PubMed ID: 11365884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glaxo Wellcome's two new drugs.
    Res Initiat Treat Action; 1998 Dec; 4(7):14. PubMed ID: 11366081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amprenavir (Agenerase).
    Simmons P
    Res Initiat Treat Action; 1999 Jul; 5(3):7-10. PubMed ID: 11366726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug approval.
    AIDS Policy Law; 1999 Apr; 14(8):12. PubMed ID: 11366532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amprenavir approved.
    STEP Perspect; 1999; 99(2):8. PubMed ID: 11366753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amprenavir, new protease inhibitor, approved.
    James JS
    AIDS Treat News; 1999 May; (No 318):1-3. PubMed ID: 11366454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New expanded access drugs for use in combination therapy.
    Newsline People AIDS Coalit N Y; 1998 Dec; ():22-3. PubMed ID: 11367085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients sought for ACTU studies that will help answer questions about drugs.
    Fac Notes (New Orleans La); 1998; 10(6):6. PubMed ID: 11366145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study: new drug doesn't display cross-resistance.
    AIDS Alert; 1999 Jul; 14(7):77. PubMed ID: 11366418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coming therapies: amprenavir.
    Gatell J
    Int J Clin Pract Suppl; 1999 Jun; 103():42-4. PubMed ID: 10622044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amprenavir made available through early access program.
    AIDS Patient Care STDS; 1998 Dec; 12(12):939-40. PubMed ID: 11362067
    [No Abstract]   [Full Text] [Related]  

  • 17. Amprenavir (Agenerase).
    Res Initiat Treat Action; 2000 Mar; 6(1):32-3. PubMed ID: 11708186
    [No Abstract]   [Full Text] [Related]  

  • 18. Expanded access.
    Proj Inf Perspect; 1999 Apr; (27):13. PubMed ID: 11366730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New protease inhibitor.
    Vazquez E
    Posit Aware; 1999; 10(3):24. PubMed ID: 11366764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Access to efavirenz and amprenavir.
    Gilden D
    GMHC Treat Issues; 1998 Oct; 12(10):12. PubMed ID: 11365902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.